Product: TB-500 (Thymosin Beta-4 fragment) lyophilized peptide 10 mg per vial
Active fragment: TB-500 (synthetic fragment of Thymosin Beta-4, amino acids 17-23)
CAS: 77591-33-4 (Thymosin Beta-4)
Molecular formula: C212H350N56O78S (full Thymosin Beta-4)
Manufacturer: BioYgen, Hong Kong
TB-500 is a synthetic fragment of Thymosin Beta-4 - a naturally occurring protein involved in tissue repair, cell migration and regeneration. It is one of the most popular recovery peptides in research and user communities, frequently paired with BPC-157.
In research literature, Thymosin Beta-4 is associated with tissue repair, wound healing and cell migration support. This is a cosmetic peptide product for injection - not a medicine.
In research and user communities, TB-500 is associated with:
The vial contains 10 mg of lyophilized TB-500. Standard dilution: add 2-4 ml of bacteriostatic water, leave in the refrigerator for 10-15 minutes, gently rotate until clear. Example: with 2 ml dilution, 1 ml contains 5,000 mcg; a 2,500 mcg dose = 0.5 ml = 50 units on a U100 insulin syringe.
Typical user protocols: higher dose (2,000-2,500 mcg) 2 times per week for 4-6 weeks (loading phase), then 2,500 mcg once per week (maintenance) - per user or consulted protocol.
Sterile product. BioYgen (Hong Kong) - manufacturer with certified production; product authenticity verifiable via QR code on the package (www.bioygen.com). Product does not contain GMOs.
TB-500 (Thymosin Beta-4 fragment) is associated with tissue repair, recovery of muscles/tendons/ligaments and anti-inflammatory support in research literature. It is a cosmetic research peptide, not an approved medicine.
Both are recovery peptides, but with different mechanisms: BPC-157 is a 15-amino-acid gastric-derived peptide focused on localized repair; TB-500 is a fragment of a systemic protein (Thymosin Beta-4) acting on cell migration throughout the body. They are frequently combined.
Standard: 2-4 ml of bacteriostatic water. With 2 ml, 1 ml contains 5,000 mcg; a 2,500 mcg dose = 0.5 ml = 50 units on a U100 syringe.
User protocols commonly start with a loading phase (higher dose twice weekly, 4-6 weeks), then switch to weekly maintenance - per user or consulted protocol.
Persons under 18, pregnant and breastfeeding women.
Ask a question or inquire about delivery to your country



